103 related articles for article (PubMed ID: 1718658)
1. An extended antigenic scheme for Yersinia pseudotuberculosis.
Aleksić S; Suchan G; Bockemühl J; Aleksić V
Contrib Microbiol Immunol; 1991; 12():235-8. PubMed ID: 1718658
[No Abstract] [Full Text] [Related]
2. A simplified antigenic scheme for serotyping of Yersinia pseudotuberculosis: phenotypic characterization of reference strains and preparation of O and H factor sera.
Tsubokura M; Aleksić S
Contrib Microbiol Immunol; 1995; 13():99-105. PubMed ID: 8833808
[No Abstract] [Full Text] [Related]
3. [Monoclonal antibodies for studying antigens of protein origin in serotyping of Yersinia pseudotuberculosis].
Fedorova VA; Sameliia ZhG; Devdariani ZL; Shvedun GP
Mol Gen Mikrobiol Virusol; 2001; (3):28-35. PubMed ID: 11534396
[TBL] [Abstract][Full Text] [Related]
4. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. IV. Specificity of antigens].
Rastawicki W
Med Dosw Mikrobiol; 2008; 60(1):27-37. PubMed ID: 18634341
[TBL] [Abstract][Full Text] [Related]
5. [Biologically active Yersinia pseudotuberculosis biopolymers].
Dzadzieva MF
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):33-7. PubMed ID: 9432843
[No Abstract] [Full Text] [Related]
6. [Molecular genetic monitoring of Yersinia pseudotuberculosis using PCR O-genotyping].
Klimov VT; Chesnokova MV
Mol Gen Mikrobiol Virusol; 2007; (4):14-7. PubMed ID: 18154076
[TBL] [Abstract][Full Text] [Related]
7. [Selection of antigens for constructing immunoenzyme test systems for pseudotuberculosis].
Sidorova VE; Bagriantsev VN; Shubin FN; Varvashevich TN
Lab Delo; 1987; (5):371-4. PubMed ID: 2441126
[No Abstract] [Full Text] [Related]
8. Seroepidemiologic study on the occurrence of antibodies against Yersinia enterocolitica and Yersinia pseudotuberculosis in urban and rural population of the Lublin region (eastern Poland).
Stojek NM
Ann Agric Environ Med; 1999; 6(1):57-61. PubMed ID: 10384217
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterisation and structural analysis of the O-specific polysaccharide of Yersinia pseudotuberculosis serotype O:1c.
De Castro C; Kenyon JJ; Cunneen MM; Reeves PR; Molinaro A; Holst O; Skurnik M
Innate Immun; 2011 Apr; 17(2):183-90. PubMed ID: 20418261
[TBL] [Abstract][Full Text] [Related]
10. [A seroepidemiological survey of the natural infection of pseudotuberculosis in human beings and animals].
Li XF
Zhonghua Liu Xing Bing Xue Za Zhi; 1987 Feb; 8(1):40-2. PubMed ID: 3304653
[No Abstract] [Full Text] [Related]
11. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
Badie G; Heithoff DM; Mahan MJ
Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
[TBL] [Abstract][Full Text] [Related]
12. The role of V antigen in mice experimentally infected with Yersinia pseudotuberculosis; histopathological study using enzyme immunoassay.
Sugiyama Y; Kaneko K; Takashima I; Hashimoto N
Nihon Juigaku Zasshi; 1986 Aug; 48(4):781-9. PubMed ID: 3531653
[No Abstract] [Full Text] [Related]
13. Pathogenic role of a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Kano H; Nogami H; Matsumoto S; Baba K; Saito H; Kohsaka T
Adv Exp Med Biol; 2003; 529():459-61. PubMed ID: 12756809
[No Abstract] [Full Text] [Related]
14. [Evaluation of the usefulness of the latex test for detection and identification of O-antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis].
Jagielski M; Kochman M; Szych J; Kałuzewski S; Rastawicki W
Med Dosw Mikrobiol; 1996; 48(1-2):31-7. PubMed ID: 8926765
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative determination of the carbohydrate determinants of O-antigens of Yersinia pseudotuberculosis and Pseudomonas fluorescens].
Naberezhnykh GA; Solov'eva TF; Ovodov IuS
Bioorg Khim; 1990 Aug; 16(8):1089-95. PubMed ID: 1704703
[TBL] [Abstract][Full Text] [Related]
16. Nonenzymatic test system for noninstrumental determination of antibodies to species-specific fibers of Yersinia pseudotuberculosis on the basis of nanosized carbon particles.
Rayev MB; Timchenko NF; Bochkova MS; Nedashkovskaya EP; Andrukov BG
Dokl Biochem Biophys; 2013; 451():221-4. PubMed ID: 23975407
[No Abstract] [Full Text] [Related]
17. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.
Chart H; Cheasty T
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375
[TBL] [Abstract][Full Text] [Related]
18. [Antigenic properties of outer membrane porins in Yersinia genus].
Novikova OD; Vostrikova OP; Portniagina OIu; Khomenko VA; Solov'eva TF; Ovodov IuS
Biull Eksp Biol Med; 1996 Jun; 121(6):657-60. PubMed ID: 9035760
[No Abstract] [Full Text] [Related]
19. Presence of Yersinia specific antibodies in hospitalized patients with arthritis and Reiter syndrome.
Constantiniu S; Chiriac R; Popovici N
Arch Roum Pathol Exp Microbiol; 1989; 48(4):341-6. PubMed ID: 2520672
[TBL] [Abstract][Full Text] [Related]
20. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
